-
1
-
-
0033824138
-
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
-
de Gasparo, M.; Catt, K. J.; Inagami, T.; Wright, J. W.; Unger, T. International Union of Pharmacology. XXIII. The Angiotensin II Receptors Pharmacol. Rev. 2000, 52, 415-472
-
(2000)
Pharmacol. Rev.
, vol.52
, pp. 415-472
-
-
De Gasparo, M.1
Catt, K.J.2
Inagami, T.3
Wright, J.W.4
Unger, T.5
-
5
-
-
0029980783
-
Angiotensin II Receptor Expression in the Conduction System and Arterial Duct of Neonatal and Adult Rat Hearts
-
Bastien, N. R.; Ciuffo, G. M.; Saavedra, J. M.; Lambert, C. Angiotensin II Receptor Expression in the Conduction System and Arterial Duct of Neonatal and Adult Rat Hearts Regul. Pept. 1996, 63, 9-16
-
(1996)
Regul. Pept.
, vol.63
, pp. 9-16
-
-
Bastien, N.R.1
Ciuffo, G.M.2
Saavedra, J.M.3
Lambert, C.4
-
6
-
-
25444533093
-
2 Receptor Expression
-
2 Receptor Expression Hypertension 2005, 46, 577-583
-
(2005)
Hypertension
, vol.46
, pp. 577-583
-
-
Okumura, M.1
Iwai, M.2
Ide, A.3
Mogi, M.4
Ito, M.5
Horiuchi, M.6
-
7
-
-
27544444083
-
Differential Expression of Angiotensin Receptors in Human Cutaneous Wound Healing
-
Steckelings, U. M.; Henz, B. M.; Wiehstutz, S.; Unger, T.; Artuc, M. Differential Expression of Angiotensin Receptors in Human Cutaneous Wound Healing Br. J. Dermatol. 2005, 153, 887-893
-
(2005)
Br. J. Dermatol.
, vol.153
, pp. 887-893
-
-
Steckelings, U.M.1
Henz, B.M.2
Wiehstutz, S.3
Unger, T.4
Artuc, M.5
-
9
-
-
11144257715
-
2 Receptor Expression after Renal Ablation
-
2 Receptor Expression after Renal Ablation Am. J. Physiol.: Renal Physiol. 2005, 288, F207-F213
-
(2005)
Am. J. Physiol.: Renal Physiol.
, vol.288
-
-
Vázquez, E.1
Coronel, I.2
Bautista, R.3
Romo, E.4
Villalón, C.M.5
Avila-Casado, C.M.6
Soto, V.7
Escalante, B.8
-
10
-
-
0028839103
-
Regulation of Gene Transcription of Angiotensin II Receptor Subtypes in Myocardial Infarction
-
Nio, Y.; Matsubara, H.; Murasawa, S.; Kanasaki, M.; Inada, M. Regulation of Gene Transcription of Angiotensin II Receptor Subtypes in Myocardial Infarction J. Clin. Invest. 1995, 95, 46-54
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 46-54
-
-
Nio, Y.1
Matsubara, H.2
Murasawa, S.3
Kanasaki, M.4
Inada, M.5
-
11
-
-
20144389630
-
2 Receptor Protects against Cerebral Ischemia-Induced Neuronal Injury
-
2 Receptor Protects against Cerebral Ischemia-Induced Neuronal Injury FASEB J. 2005, 19, 617-619
-
(2005)
FASEB J.
, vol.19
, pp. 617-619
-
-
Li, J.1
Culman, J.2
Hortnagl, H.3
Zhao, Y.4
Gerova, N.5
Timm, M.6
Blume, A.7
Zimmermann, M.8
Seidel, K.9
Dirnagl, U.10
Unger, T.11
-
12
-
-
0037340033
-
2 Receptor in Postinfarction Left Ventricular Remodeling
-
2 Receptor in Postinfarction Left Ventricular Remodeling Hypertension 2003, 41, 814-818
-
(2003)
Hypertension
, vol.41
, pp. 814-818
-
-
Oishi, Y.1
Ozono, R.2
Yano, Y.3
Teranishi, Y.4
Akishita, M.5
Horiuchi, M.6
Oshima, T.7
Kambe, M.8
-
13
-
-
65249180615
-
2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke
-
2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke Stroke 2009, 40, 1482-1489
-
(2009)
Stroke
, vol.40
, pp. 1482-1489
-
-
McCarthy, C.A.1
Vinh, A.2
Callaway, J.K.3
Widdop, R.E.4
-
14
-
-
0642273041
-
2 Receptor and the Transcription Factor NF-kappaB
-
2 Receptor and the Transcription Factor NF-kappaB FASEB J. 2003, 17, 2094-2096
-
(2003)
FASEB J.
, vol.17
, pp. 2094-2096
-
-
Reinecke, K.1
Lucius, R.2
Reinecke, A.3
Rickert, U.4
Herdegen, T.5
Unger, T.6
-
15
-
-
77950472601
-
Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor kappaB
-
Rompe, F.; Artuc, M.; Hallberg, A.; Alterman, M.; Stroder, K.; Thone-Reineke, C.; Reichenbach, A.; Schacherl, J.; Dahlof, B.; Bader, M.; Alenina, N.; Schwaninger, M.; Zuberbier, T.; Funke-Kaiser, H.; Schmidt, C.; Schunck, W. H.; Unger, T.; Steckelings, U. M. Direct Angiotensin II Type 2 Receptor Stimulation Acts Anti-Inflammatory through Epoxyeicosatrienoic Acid and Inhibition of Nuclear Factor kappaB Hypertension 2010, 55, 924-931
-
(2010)
Hypertension
, vol.55
, pp. 924-931
-
-
Rompe, F.1
Artuc, M.2
Hallberg, A.3
Alterman, M.4
Stroder, K.5
Thone-Reineke, C.6
Reichenbach, A.7
Schacherl, J.8
Dahlof, B.9
Bader, M.10
Alenina, N.11
Schwaninger, M.12
Zuberbier, T.13
Funke-Kaiser, H.14
Schmidt, C.15
Schunck, W.H.16
Unger, T.17
Steckelings, U.M.18
-
16
-
-
0034968002
-
Angiotensin II Type 2 Receptor-Mediated Duodenal Mucosal Alkaline Secretion in the Rat
-
Johansson, B.; Holm, M.; Ewert, S.; Casselbrant, A.; Pettersson, A.; Fändriks, L. Angiotensin II Type 2 Receptor-Mediated Duodenal Mucosal Alkaline Secretion in the Rat Am. J. Physiol. 2001, 280, G1254-G1260
-
(2001)
Am. J. Physiol.
, vol.280
-
-
Johansson, B.1
Holm, M.2
Ewert, S.3
Casselbrant, A.4
Pettersson, A.5
Fändriks, L.6
-
17
-
-
0347989300
-
2 Receptor of Angiotensin II and Neuronal Differentiation: From Observations to Mechanisms
-
2 Receptor of Angiotensin II and Neuronal Differentiation: From Observations to Mechanisms J. Mol. Endocrinol. 2003, 31, 359-372
-
(2003)
J. Mol. Endocrinol.
, vol.31
, pp. 359-372
-
-
Gendron, L.1
Payet, M.2
Gallo-Payet, N.3
-
18
-
-
41149099225
-
2 Receptors: Control of Renal Sodium Excretion and Blood Pressure
-
2 Receptors: Control of Renal Sodium Excretion and Blood Pressure Trends Endocrinol. Metab. 2008, 19, 84-87
-
(2008)
Trends Endocrinol. Metab.
, vol.19
, pp. 84-87
-
-
Carey, R.M.1
Padia, S.H.2
-
19
-
-
67651108610
-
The Potential Role of the Angiotensin Subtype 2 Receptor in Cardiovascular Protection
-
Siragy, H. M. The Potential Role of the Angiotensin Subtype 2 Receptor in Cardiovascular Protection Curr. Hypertens. Rep. 2009, 11, 260-262
-
(2009)
Curr. Hypertens. Rep.
, vol.11
, pp. 260-262
-
-
Siragy, H.M.1
-
21
-
-
8644281991
-
2 Receptor Agonist
-
2 Receptor Agonist J. Med. Chem. 2004, 47, 5995-6008
-
(2004)
J. Med. Chem.
, vol.47
, pp. 5995-6008
-
-
Wan, Y.1
Wallinder, C.2
Plouffe, B.3
Beaudry, H.4
Mahalingam, A.K.5
Wu, X.6
Johansson, B.7
Holm, M.8
Botros, M.9
Karlen, A.10
Pettersson, A.11
Nyberg, F.12
Faendriks, L.13
Gallo-Payet, N.14
Hallberg, A.15
Alterman, M.16
-
22
-
-
58149375072
-
Angiotensin II Type 2 Receptor Stimulation: A Novel Option of Therapeutic Interference with the Renin-Angiotensin System in Myocardial Infarction?
-
Kaschina, E.; Grzesiak, A.; Li, J.; Foryst-Ludwig, A.; Timm, M.; Rompe, F.; Sommerfeld, M.; Kemnitz, U. R.; Curato, C.; Namsolleck, P.; Tschope, C.; Hallberg, A.; Alterman, M.; Hucko, T.; Paetsch, I.; Dietrich, T.; Schnackenburg, B.; Graf, K.; Dahlof, B.; Kintscher, U.; Unger, T.; Steckelings, U. M. Angiotensin II Type 2 Receptor Stimulation: A Novel Option of Therapeutic Interference with the Renin-Angiotensin System in Myocardial Infarction? Circulation 2008, 118, 2523-2532
-
(2008)
Circulation
, vol.118
, pp. 2523-2532
-
-
Kaschina, E.1
Grzesiak, A.2
Li, J.3
Foryst-Ludwig, A.4
Timm, M.5
Rompe, F.6
Sommerfeld, M.7
Kemnitz, U.R.8
Curato, C.9
Namsolleck, P.10
Tschope, C.11
Hallberg, A.12
Alterman, M.13
Hucko, T.14
Paetsch, I.15
Dietrich, T.16
Schnackenburg, B.17
Graf, K.18
Dahlof, B.19
Kintscher, U.20
Unger, T.21
Steckelings, U.M.22
more..
-
23
-
-
79954416372
-
2-Receptor Agonists
-
2-Receptor Agonists Curr. Opin. Pharmacol. 2010, 11, 187-192
-
(2010)
Curr. Opin. Pharmacol.
, vol.11
, pp. 187-192
-
-
Steckelings, U.M.1
Larhed, M.2
Hallberg, A.3
Widdop, R.E.4
Jones, E.S.5
Wallinder, C.6
Namsolleck, P.7
Dahlof, B.8
Unger, T.9
-
24
-
-
79959950762
-
Novel Therapeutic Targets for the Treatment of Heart Failure
-
Tamargo, J.; López-Sendón, J. Novel Therapeutic Targets for the Treatment of Heart Failure Nat. Rev. Drug Discovery 2011, 10, 536-555
-
(2011)
Nat. Rev. Drug Discovery
, vol.10
, pp. 536-555
-
-
Tamargo, J.1
López-Sendón, J.2
-
29
-
-
0028931963
-
1 Receptor
-
1 Receptor J. Biol. Chem. 1995, 270, 1493-1496
-
(1995)
J. Biol. Chem.
, vol.270
, pp. 1493-1496
-
-
Perlman, S.1
Schambye, H.T.2
Rivero, R.A.3
Greenlee, W.J.4
Hjorth, S.A.5
Schwartz, T.W.6
-
30
-
-
0028928407
-
Discovery of L-162,313: A Nonpeptide That Mimics the Biological Actions of Angiotensin II
-
Kivlighn, S. D.; Huckle, W. R.; Zingaro, G. J.; Rivero, R. A.; Lotti, V. J.; Chang, R. S. L.; Schorn, T. W.; Kevin, N.; Johnson, R. G., Jr. Discovery of L-162,313: A Nonpeptide That Mimics the Biological Actions of Angiotensin II Am. J. Physiol. 1995, 268, R820-R823
-
(1995)
Am. J. Physiol.
, vol.268
-
-
Kivlighn, S.D.1
Huckle, W.R.2
Zingaro, G.J.3
Rivero, R.A.4
Lotti, V.J.5
Chang, R.S.L.6
Schorn, T.W.7
Kevin, N.8
Johnson Jr., R.G.9
-
31
-
-
1542268165
-
2 Receptor Agonist in Vivo
-
2 Receptor Agonist in Vivo J. Med. Chem. 2004, 47, 1536-1546
-
(2004)
J. Med. Chem.
, vol.47
, pp. 1536-1546
-
-
Wan, Y.1
Wallinder, C.2
Johansson, B.3
Holm, M.4
Mahalingam, A.K.5
Wu, X.6
Botros, M.7
Karlen, A.8
Pettersson, A.9
Nyberg, F.10
Faendriks, L.11
Hallberg, A.12
Alterman, M.13
-
32
-
-
0031035850
-
1 Ligands: Susceptibility to Receptor Mutations
-
1 Ligands: Susceptibility to Receptor Mutations Mol. Pharmacol. 1997, 51, 301-311
-
(1997)
Mol. Pharmacol.
, vol.51
, pp. 301-311
-
-
Perlman, S.1
Costa-Neto, C.M.2
Miyakawa, A.A.3
Schambye, H.T.4
Hjort, S.A.5
Paiva, A.C.M.6
Rivero, R.A.7
Greenlee, W.J.8
Schwartz, T.W.9
-
33
-
-
12144290765
-
2 Receptor Ligand with a γ-Turn-like Mimetic Replacing the Amino Acid Residues 4-5 of Angiotensin II
-
2 Receptor Ligand with a γ-Turn-like Mimetic Replacing the Amino Acid Residues 4-5 of Angiotensin II J. Med. Chem. 2004, 47, 859-70
-
(2004)
J. Med. Chem.
, vol.47
, pp. 859-70
-
-
Rosenström, U.1
Sköld, C.2
Lindeberg, G.3
Botros, M.4
Nyberg, F.5
Karlén, A.6
Hallberg, A.7
-
34
-
-
20444372614
-
2 Receptor Ligands Encompassing a γ-Turn Mimetic Replacing the Amino Acid Residues 4-5 of Angiotensin II Act as Agonists
-
2 Receptor Ligands Encompassing a γ-Turn Mimetic Replacing the Amino Acid Residues 4-5 of Angiotensin II Act as Agonists J. Med. Chem. 2005, 48, 4009-4024
-
(2005)
J. Med. Chem.
, vol.48
, pp. 4009-4024
-
-
Rosenström, U.1
Sköld, C.2
Plouffe, B.3
Lindeberg, G.4
Botros, M.5
Nyberg, F.6
Wolf, G.7
Karlén, A.8
Gallo-Payet, N.9
Hallberg, A.10
-
35
-
-
27144503116
-
2 Receptor Affinity
-
2 Receptor Affinity J. Med. Chem. 2005, 48, 6620-6631
-
(2005)
J. Med. Chem.
, vol.48
, pp. 6620-6631
-
-
Georgsson, J.1
Sköld, C.2
Plouffe, B.3
Lindeberg, G.4
Botros, M.5
Larhed, M.6
Nyberg, F.7
Gallo-Payet, N.8
Gogoll, A.9
Karlen, A.10
Hallberg, A.11
-
36
-
-
33749256952
-
2 Receptors
-
2 Receptors J. Med. Chem. 2006, 49, 6133-6137
-
(2006)
J. Med. Chem.
, vol.49
, pp. 6133-6137
-
-
Rosenström, U.1
Sköld, C.2
Lindeberg, G.3
Botros, M.4
Nyberg, F.5
Karlén, A.6
Hallberg, A.7
-
37
-
-
33746040078
-
2 Receptor Affinity
-
2 Receptor Affinity Bioorg. Med. Chem. 2006, 14, 5963-5972
-
(2006)
Bioorg. Med. Chem.
, vol.14
, pp. 5963-5972
-
-
Georgsson, J.1
Rosenström, U.2
Wallinder, C.3
Beaudry, H.4
Plouffe, B.5
Lindeberg, G.6
Botros, M.7
Nyberg, F.8
Karlen, A.9
Gallo-Payet, N.10
Hallberg, A.11
-
38
-
-
34147130733
-
2 Receptor
-
2 Receptor J. Med. Chem. 2007, 50, 1711-1715
-
(2007)
J. Med. Chem.
, vol.50
, pp. 1711-1715
-
-
Georgsson, J.1
Sköld, C.2
Botoros, M.3
Lindeberg, G.4
Nyberg, F.5
Karlen, A.6
Hallberg, A.7
Larhed, M.8
-
39
-
-
33845362252
-
2 Receptor Agonists: Arylbenzylimidazole Structure-Activity Relationships
-
2 Receptor Agonists: Arylbenzylimidazole Structure-Activity Relationships J. Med. Chem. 2006, 49, 7160-7168
-
(2006)
J. Med. Chem.
, vol.49
, pp. 7160-7168
-
-
Wu, X.1
Wan, Y.2
Mahalingam, A.K.3
Murugaiah, A.M.S.4
Plouffe, B.5
Botros, M.6
Karlén, A.7
Hallberg, M.8
Gallo-Payet, N.9
Alterman, M.10
-
40
-
-
34548849480
-
2 Receptor Agonists Devoid of the Imidazole Ring System
-
2 Receptor Agonists Devoid of the Imidazole Ring System Bioorg. Med. Chem. 2007, 15, 7166-7183
-
(2007)
Bioorg. Med. Chem.
, vol.15
, pp. 7166-7183
-
-
Murugaiah, A.M.S.1
Wallinder, C.2
Mahalingam, A.K.3
Wu, X.4
Wan, Y.5
Plouffe, B.6
Botros, M.7
Karlén, A.8
Hallberg, M.9
Gallo-Payet, N.10
Alterman, M.11
-
41
-
-
47349109091
-
2 Receptor Agonists: Benzamide Structure-Activity Relationships
-
2 Receptor Agonists: Benzamide Structure-Activity Relationships Bioorg. Med. Chem. 2008, 16, 6841-6849
-
(2008)
Bioorg. Med. Chem.
, vol.16
, pp. 6841-6849
-
-
Wallinder, C.1
Botros, M.2
Rosenström, U.3
Guimond, M.-O.4
Beaudry, H.5
Nyberg, F.6
Gallo-Payet, N.7
Hallberg, A.8
Alterman, M.9
-
42
-
-
77953130398
-
2 Receptor Agonists with Reduced CYP 450 Inhibition
-
2 Receptor Agonists with Reduced CYP 450 Inhibition Bioorg. Med. Chem. 2010, 18, 4570-4590
-
(2010)
Bioorg. Med. Chem.
, vol.18
, pp. 4570-4590
-
-
Mahalingam, A.K.1
Wan, Y.2
Murugaiah, A.M.S.3
Wallinder, C.4
Wu, X.5
Plouffe, B.6
Botros, M.7
Nyberg, F.8
Hallberg, A.9
Gallo-Payet, N.10
Alterman, M.11
-
43
-
-
0026335409
-
2 Subtype
-
2 Subtype J. Med. Chem. 1991, 34, 3248-3260
-
(1991)
J. Med. Chem.
, vol.34
, pp. 3248-3260
-
-
Blankley, C.J.1
Hodges, J.C.2
Klutchko, S.R.3
Himmelsbach, R.J.4
Chucholowski, A.5
Connolly, C.J.6
Neergaard, S.J.7
Van Nieuwenhze, M.S.8
Sebastian, A.9
Quin III, J.10
Essenburg, A.D.11
Cohen, D.M.12
-
45
-
-
0038403917
-
Boron Trichloride as an Efficient and Selective Agent for Deprotection of tert -Butyl Aryl Sulfonamides
-
Wan, Y.; Wu, X.; Mahalingam, A. K.; Alterman, M. Boron Trichloride as an Efficient and Selective Agent for Deprotection of tert -Butyl Aryl Sulfonamides Tetrahedron Lett. 2003, 44, 4523-4525
-
(2003)
Tetrahedron Lett.
, vol.44
, pp. 4523-4525
-
-
Wan, Y.1
Wu, X.2
Mahalingam, A.K.3
Alterman, M.4
-
46
-
-
0025195614
-
Subclasses of Angiotensin II Binding Sites and Their Functional Significance
-
Dudley, D. T.; Panek, R. L.; Major, T. C.; Lu, G. H.; Bruns, R. F.; Klinkefus, B. A.; Hodges, J. C.; Weishaar, R. E. Subclasses of Angiotensin II Binding Sites and Their Functional Significance Mol. Pharmacol. 1990, 38, 370-377
-
(1990)
Mol. Pharmacol.
, vol.38
, pp. 370-377
-
-
Dudley, D.T.1
Panek, R.L.2
Major, T.C.3
Lu, G.H.4
Bruns, R.F.5
Klinkefus, B.A.6
Hodges, J.C.7
Weishaar, R.E.8
-
50
-
-
0033237655
-
2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Pprotein Kinase) to Induce Morphological Neuronal Differentiation in NG108-15 Cells
-
2 (Angiotensin Type 2) Receptor of Angiotensin II Inhibit p21ras and Activate MAPK (Mitogen-Activated Pprotein Kinase) To Induce Morphological Neuronal Differentiation in NG108-15 Cells Mol. Endocrinol. 1999, 13, 1615-1626
-
(1999)
Mol. Endocrinol.
, vol.13
, pp. 1615-1626
-
-
Gendron, L.1
Laflamme, L.2
Rivard, N.3
Asselin, C.4
Payet, M.D.5
Gallo-Payet, N.6
-
51
-
-
0036159731
-
Nitric Oxide and Cyclic GMP are Involved in Angiotensin II AT(2) Receptor Effects on Neurite Outgrowth in NG108-15 Cells
-
Gendron, L.; Cote, F.; Payet, M. D.; Gallo-Payet, N. Nitric Oxide and Cyclic GMP are Involved in Angiotensin II AT(2) Receptor Effects on Neurite Outgrowth in NG108-15 Cells Neuroendocrinology 2002, 75, 70-81
-
(2002)
Neuroendocrinology
, vol.75
, pp. 70-81
-
-
Gendron, L.1
Cote, F.2
Payet, M.D.3
Gallo-Payet, N.4
-
52
-
-
51849099001
-
Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119
-
Semple, G.; Fioravanti, B.; Pereira, G.; Calderon, I.; Uy, J.; Choi, K.; Xiong, Y.; Ren, A.; Morgan, M.; Dave, V.; Thomsen, W.; Unett, D. J.; Xing, C.; Bossie, S.; Carroll, C.; Chu, Z.-L.; Grottick, A. J.; Hauser, E. K.; Leonard, J.; Jones, R. M. Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119 J. Med. Chem. 2008, 51, 5172-5175
-
(2008)
J. Med. Chem.
, vol.51
, pp. 5172-5175
-
-
Semple, G.1
Fioravanti, B.2
Pereira, G.3
Calderon, I.4
Uy, J.5
Choi, K.6
Xiong, Y.7
Ren, A.8
Morgan, M.9
Dave, V.10
Thomsen, W.11
Unett, D.J.12
Xing, C.13
Bossie, S.14
Carroll, C.15
Chu, Z.-L.16
Grottick, A.J.17
Hauser, E.K.18
Leonard, J.19
Jones, R.M.20
more..
-
53
-
-
0000801464
-
Nonpeptide Agonists for Peptide Receptors: Lessons from Ligands
-
Sugg, E. Nonpeptide Agonists for Peptide Receptors: Lessons from Ligands Annu. Rep. Med. Chem. 1997, 32, 277-283
-
(1997)
Annu. Rep. Med. Chem.
, vol.32
, pp. 277-283
-
-
Sugg, E.1
-
54
-
-
0028968949
-
Tyrosine Kinase Inhibition: An Approach to Drug Development
-
Levitzki, A.; Gazit, A. Tyrosine Kinase Inhibition: An Approach to Drug Development Science 1995, 267, 1782-1788
-
(1995)
Science
, vol.267
, pp. 1782-1788
-
-
Levitzki, A.1
Gazit, A.2
-
55
-
-
33748743094
-
2 Receptor Signaling: Involvement in Neurite Outgrowth and in p42/p44mapk Activation in NG108-15 Cells
-
2 Receptor Signaling: Involvement in Neurite Outgrowth and in p42/p44mapk Activation in NG108-15 Cells Endocrinology 2006, 147, 4646-4654
-
(2006)
Endocrinology
, vol.147
, pp. 4646-4654
-
-
Plouffe, B.1
Guimond, M.-O.2
Beaudry, H.3
Gallo-Payet, N.4
-
56
-
-
84863231863
-
-
The agonist M024 is also known as compound 21 (C21).
-
The agonist M024 is also known as compound 21 (C21).
-
-
-
|